Overview / Abstract: |
The most recent estimates from the Centers for Disease Control and Prevention (CDC) state that approximately 37,000 people in the United States become infected with HIV each year.1 To reduce the number of new infections, health care providers should be prepared to discuss the potential benefits of preexposure prophylaxis (PrEP) with adults who are at particularly high risk for acquiring HIV.2 The United States Public Health Service (USPHS) and the CDC have published clinical practice guidelines on identifying candidates and prescribing medication approved by the US Food and Drug Administration (FDA) for HIV PrEP.3 During this Interactive Exchange™ program, expert faculty will review these guidelines with a focus on how pharmacists can facilitate patient engagement and retention in HIV-prevention services.4 Key topics will include recommendations on universal HIV testing, cohorts at substantial risk for HIV acquisition, criteria for PrEP eligibility, and practical approaches to monitoring PrEP outcomes and adherence.1 Faculty will also discuss the growing evidence pool supporting pharmacy-based programs to highlight opportunities for program attendees to play increasingly central roles in the prevention of new HIV infections.5 References: |
Expiration |
Mar 05, 2019 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.0 |
Accreditation |
ACPE, ANCC, ACCME, CE |
Presenters / Authors / Faculty |
Richard A. Elion, MD; James D. Scott, BS, MEd, PharmD; Elyse Tung, PharmD, BCACP |
Sponsors / Supporters / Grant Providers |
This activity has been supported by an independent educational grant from Gilead Sciences, Inc and jointly provided by Postgraduate Institute for Medicine and Integritas Communications. |
Keywords / Search Terms |
Integritas Communications, ACPE, ANCC, ACCME, credit, Pharmacist, HIV, prevention, PrEP, Free CE, Free CME, CME, CE, human immunodeficiency virus, Pre-exposure prophylaxis, Continuing Medical Education, Continuing Education, video, webcast, Elion, Scott, Tung, Centers for Disease Control and Prevention, CDC, United States Public Health Service, USPHS, US Food and Drug Administration, FDA, Interactive Exchange |